KR20150131270A - 머스캐딘 부산물 추출물을 제조하는 방법 - Google Patents

머스캐딘 부산물 추출물을 제조하는 방법 Download PDF

Info

Publication number
KR20150131270A
KR20150131270A KR1020157029287A KR20157029287A KR20150131270A KR 20150131270 A KR20150131270 A KR 20150131270A KR 1020157029287 A KR1020157029287 A KR 1020157029287A KR 20157029287 A KR20157029287 A KR 20157029287A KR 20150131270 A KR20150131270 A KR 20150131270A
Authority
KR
South Korea
Prior art keywords
extract
muscadine
purple
product
bronze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020157029287A
Other languages
English (en)
Korean (ko)
Inventor
테오도로 티. 이아니로
로럴 에이. 피셔
Original Assignee
샤클리 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/828,707 external-priority patent/US9173916B2/en
Application filed by 샤클리 코포레이션 filed Critical 샤클리 코포레이션
Publication of KR20150131270A publication Critical patent/KR20150131270A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A23L1/3002—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A23L2/04—Extraction of juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
KR1020157029287A 2013-03-14 2014-03-12 머스캐딘 부산물 추출물을 제조하는 방법 Ceased KR20150131270A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/828,707 US9173916B2 (en) 2008-07-31 2013-03-14 Method of preparing a muscadine pomace extract
US13/828,707 2013-03-14
PCT/US2014/024717 WO2014159677A1 (fr) 2013-03-14 2014-03-12 Procédé de préparation d'un extrait de grignon de muscadine

Publications (1)

Publication Number Publication Date
KR20150131270A true KR20150131270A (ko) 2015-11-24

Family

ID=51625227

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157029287A Ceased KR20150131270A (ko) 2013-03-14 2014-03-12 머스캐딘 부산물 추출물을 제조하는 방법

Country Status (9)

Country Link
JP (1) JP6445518B2 (fr)
KR (1) KR20150131270A (fr)
CN (1) CN105188419B (fr)
CA (1) CA2904636C (fr)
MX (1) MX366664B (fr)
MY (1) MY171947A (fr)
PH (1) PH12015501949A1 (fr)
TW (1) TWI621444B (fr)
WO (1) WO2014159677A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102698515B1 (ko) 2023-11-30 2024-08-26 주식회사 디캔트 열매가공 부산물로부터 얻어진 방향 조성물과 이를 이용한 향료
KR102736648B1 (ko) 2023-11-30 2024-12-03 주식회사 디캔트 주류생산 부산물의 가공 분말과 이를 이용한 건강식품 또는 의약품 첨가용 부형제

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7241483B2 (ja) * 2018-07-23 2023-03-17 株式会社ノエビア 皮膚用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283553B2 (ja) * 1991-12-10 2002-05-20 株式会社創研 化粧料
US6190716B1 (en) * 1999-02-17 2001-02-20 Scott O. Galbreath, Jr. Method for preparing a grape derived product
JP5010077B2 (ja) * 2001-09-05 2012-08-29 ライオン株式会社 エラグ酸分散物及び外用剤組成物
US20040234671A1 (en) * 2003-05-20 2004-11-25 Ector Betty J. Houston Method and system for processing muscadine grape pomace
US20060024392A1 (en) * 2004-04-20 2006-02-02 The University Of Maryland Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
BRPI0621321A2 (pt) * 2006-02-10 2011-12-06 Mannatech Inc formulações de suplemento dietético de multivitamìnico e multimineral natural para melhor absorção e utilização biológica
US20100004344A1 (en) * 2007-01-17 2010-01-07 Nbc Nutraceutic Business Consulting Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition
EP2033526A1 (fr) * 2007-09-07 2009-03-11 Probelte Pharma, S.A. Produits nutritifs comportant des extraits de grenade contenant des tanins ellagiques et leur utilisation
US9173916B2 (en) * 2008-07-31 2015-11-03 Shaklee Corporation Method of preparing a muscadine pomace extract
CN102164508B (zh) * 2008-07-31 2015-04-01 嘉康利公司 具有增加的抗氧化活性的麝香葡萄组合物
TWI484918B (zh) * 2008-07-31 2015-05-21 Shaklee Corp 製備麝香葡萄果漿萃取物的方法
MX2011001183A (es) * 2008-07-31 2011-03-30 Shaklee Corp Metodo para preparar un extracto de begazo de muscadine.
EP2581089B1 (fr) * 2010-06-09 2019-09-04 Kao Corporation Procédé de fabrication d'une composition de polyphénol

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102698515B1 (ko) 2023-11-30 2024-08-26 주식회사 디캔트 열매가공 부산물로부터 얻어진 방향 조성물과 이를 이용한 향료
KR102736648B1 (ko) 2023-11-30 2024-12-03 주식회사 디캔트 주류생산 부산물의 가공 분말과 이를 이용한 건강식품 또는 의약품 첨가용 부형제

Also Published As

Publication number Publication date
MX2015012676A (es) 2016-02-16
TW201501721A (zh) 2015-01-16
MY171947A (en) 2019-11-08
PH12015501949A1 (en) 2016-01-11
JP2016518110A (ja) 2016-06-23
CN105188419A (zh) 2015-12-23
CA2904636C (fr) 2021-05-04
WO2014159677A1 (fr) 2014-10-02
JP6445518B2 (ja) 2018-12-26
CN105188419B (zh) 2018-06-19
CA2904636A1 (fr) 2014-10-02
TWI621444B (zh) 2018-04-21
HK1219209A1 (zh) 2017-03-31
MX366664B (es) 2019-07-18

Similar Documents

Publication Publication Date Title
CA2732306C (fr) Composition de muscadine possedant une activite antioxydante amelioree
Ozga et al. Characterization of cyanidin-and quercetin-derived flavonoids and other phenolics in mature saskatoon fruits (Amelanchier alnifolia Nutt.)
US9421189B2 (en) Method of preparing a muscadine pomace extract
DE60106214T2 (de) Verbesserung der löslichkeit von flavonolen
US20150086655A1 (en) Morinda Citrifolia Juice Formulations Comprising Iridoids
JP2013520515A (ja) モリンダ・シトリフォリアおよびイリドイドをベースとする処方物
US20120328720A1 (en) Iridoid Based Formulations
Sharma et al. Current findings and future prospective of high-value trans Himalayan medicinal plant Lycium ruthenicum Murr: a systematic review
EP2805722B1 (fr) Extrait d'olive contenant du dérhamnosyl-actéoside
US9132162B2 (en) Muscadine compositions with anti-oxidant activity
US9173916B2 (en) Method of preparing a muscadine pomace extract
Djordjević Phenolics compounds in fruits of different types of berries and their beneficent for human health
TWI621444B (zh) 製備麝香葡萄果漿萃取物的方法
Noguera et al. Emerging berries from the Brazilian Amazon and Atlantic Forest biomes: new sources of bioactive compounds with potential health benefits
Guaâdaoui et al. The preventive approach of biocompounactives (2): a review in recent advances in common fruits
KR20190059536A (ko) 활성형 진노세사이드 함유 아로니아 음료조성물 및 그 제조방법
Lim Fragaria x ananassa
Galetti A competitive assessment commercial elderberry (Sambucus sp.) products and the evaluation of Copigmentation within elderberry tinctures
Alqurashi et al. Bioactive compounds of arid and semiarid fruits: Impact on human health
KR100912290B1 (ko) 신규6,8-디(γ,γ-디메틸알릴)-3,5,7,2',4',6'-헥사히드록시플라바논 또는 이의 약학적으로 허용가능한 염, 이의제조방법 및 이를 유효성분으로 함유하는 숙취 해소용조성물
HK1219209B (en) Method of preparing a muscadine pomace extract
Khan et al. Investigation of Polymeric Nanoparticles Encapsulating Natural Sources for Targeting of Cancer
Sepúlveda et al. POMEGRANATE: CULTIVATION, ANTIOXIDANT PROPERTIES AND ITS HEALTH BENEFITS

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000